HTG Molecular to Present Corporate Overview at the Cantor 2019 Global Healthcare Conference
|HTG Molecular Presentation Details |
|Date:||Thursday, October 3|
|Time:||8:20 am Eastern Time|
HTG is focused on NGS-based molecular profiling. The company’s proprietary HTG EdgeSeq technology automates complex, highly multiplexed molecular profiling from solid and liquid samples, even when limited in amount. HTG’s customers use its technology to identify biomarkers important for precision medicine, to understand the clinical relevance of these discoveries, and ultimately to identify treatment options. The company’s mission is to empower precision medicine.
LifeSci Advisors, LLC
Phone: (617) 535-7742
Chief Financial Officer
Source: HTG Molecular Diagnostics, Inc.